GPT-5 Pro helped solve a 3-year-old immunology mystery, offering insights into T cell behavior. The breakthrough could support cancer and autoimmune research.
Latest Briefs
Fast updates from the latest stories.
COMPANIES
+2
ESDS eyes debut as India’s first listed data centre operator with ₹720-crore IPO
Jun 29, 2026
GOVERNMENT
+2
UK Allocates £580 Million for Defence Technology Lab Expansion
Jun 29, 2026
COMPANIES
+2
Nagarro deal jitters drag Persistent's shares to a two-year low
Jun 29, 2026
COMPANIES
+3
Fluence deal signals Honasa’s pivot towards health-beauty convergence
Jun 29, 2026